JPRN-UMIN000054187尚未招募Unknown
An exploratory clinical trial on the effects of nicotinamide mononucleotide (NMN) intake and exercises on skeletal muscle mass and function in older adults with reduced skeletal muscle mass. - An exploratory clinical trial on the effects of nicotinamide mononucleotide (NMN) intake and exercise on skeletal muscle in older adults.
Tokyo Metropolitan Institute for Geriatrics and Gerontology0 个研究点目标入组 70 人开始时间: 2024年4月19日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1).The subjects with a history of heart failure, neurodegenerative disease, or Parkinson's disease. 2).The subjects undergoing treatment for malignancy, atrial fibrillation, arrhythmias, hepatic disorders, renal disorders, cerebrovascular disorders, rheumatism, diabetes mellitus, or other chronic diseases. 3).The subjects undergoing treatment for sleep disorders (insomnia), depression or other psychiatric disorders. 4).The subjects with dementia or an MMSE (Mini-Mental State Examination) score of less than 23 points. 5).The subjects who may develop allergic symptoms to the test food (vitamins), or to any other food or drug. 6).The subjects who habitually consume food supplements or nutritional/energy drinks containing NMN or niacin (vitamin B3, nicotinamide, nicotinic acid amide). 7).The subjects who habitually take medicines, specified health foods, or health foods that may affect aging, such as drugs with antioxidant properties. 8).The subjects who are prohibited from exercising by a physician. 9).Currently, subjects who are participating in another clinical trial, have participated in another clinical trial within the past 3 months, or may participate in another trial during the duration of this trial. 10).The subjects who are known in advance to be unable to attend exercise classes on a regular basis (at least 5 out of 8 times a month). 11).The subjects who are judged to have difficulty communicating in Japanese. 12).The subjects deemed ineligible by the clinical investigator.
研究者
相似试验
尚未招募
1 期
A clinical trial for the efficacy and safety of new Chinese herbal compound in reducing uric acid in patientsHyperuricemiaITMCTR2000003495Tongren of Traditional Chinese Medicine
进行中（未招募）
不适用
A trial investigating the efficacy and safety of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimetype 1 diabetes mellitusEUCTR2009-011672-29-FIovo Nordisk A/S426
已完成
3 期
Comparison of NN1250 plus insulin Aspart with insulin Detemir plus insulin Aspart in type 1 diabetes.CTRI/2010/091/000145ovo Nordisk AS60
进行中（未招募）
不适用
A trial investigating the efficacy and safety of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimen - BEGIN : BB T1type 1 diabetesEUCTR2009-011672-29-ITOVO NORDISK426
进行中（未招募）
1 期
A trial investigating the efficacy and safety of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimeMedDRA version: 12.0 Level: LLT Classification code 10045228 Term: Type I diabetes mellitustype 1 diabetes mellitusEUCTR2009-011672-29-GBovo Nordisk A/S